Imagine being able to check if a newborn has jaundice just by using a smartphone app at home instead of rushing to the hospital. This tool acts like a digital eye that spots yellowing of the skin early, helping parents know exactly when a baby needs a doctor. It turns a phone into a medical screening device to prevent serious brain damage in infants.
Current neonatal jaundice screening relies on insufficient visual assessments or expensive clinic visits, leading to 114,000 deaths annually and overburdened health systems.
A digital platform called Jaundice@Home and a smartphone-based medical device called Picterus Jaundice Pro for home-based screening and referral.
If you are a digital health provider dealing with the lack of remote monitoring for newborns — this project developed the Jaundice@Home platform that enables parents to screen for jaundice at home. This reduces unnecessary emergency visits and improves healthcare efficiency.
If you are a health system dealing with increasing pressure on resources and 60-80% of newborns affected by jaundice — this project developed a smartphone-based medical device that facilitates timely referrals. This leads to substantial cost savings and better operational capacity.
If you are a device manufacturer dealing with the insufficiency of visual assessments and transcutaneous devices — this project developed Picterus Jaundice Pro. This tool provides an affordable, point-of-care screening method for the first 2 weeks of life.
Based on available project data, specific pricing is not mentioned, but the project highlights substantial cost savings and the development of an affordable screening method.
Yes, the platform is already commercially deployed and clinical studies in diverse settings have validated its scalability.
Based on available project data, the project has achieved successful registrations in multiple countries for the Picterus Jaundice Pro device.
The platform uses a secure, GDPR-compliant architecture with role-based access control to ensure data privacy.
The system is designed for interoperability with healthcare systems, allowing healthcare workers to manage families efficiently and avoid unnecessary visits.
The project is led by a single SME, PICTERUS AS from Norway. With a 100% industry ratio and no university or research partners, the consortium is lean and focused entirely on commercial execution and market deployment.
Contact PICTERUS AS in Norway
Contact us to explore licensing opportunities for the Jaundice@Home platform.
